Clinical trial Recruiting at 1 site Interventional Ages 18 to 30

Functional brain signal changes after ACL reconstruction with targeted neuromotor training

Official title: Study of Functional Magnetic Resonance Signal Variations in Patients Undergoing Anterior Cruciate Ligament Reconstruction With the Application of a Dedicated Neuromotor Training

Run by Istituto Ortopedico Rizzoli · NCT07097077 · Data updated 2026-11-12

This project will test whether targeted neuromotor training after ACL reconstruction changes brain activity patterns in active adults aged 18–30.

Quick facts

Study typeInterventional
Ages18 Years to 30 Years
SexAll
Enrollment12 (estimated)
SponsorIstituto Ortopedico Rizzoli
Academic / other
Locations1 site (Bologna, Bologna)
StatusRecruiting
StartedFebruary 7, 2026
Main results expectedJuly 2027
Study endsJuly 2027
Registry record updatedFebruary 27, 2026
Trial IDNCT07097077 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18–30 who have had ACL reconstruction, are highly active (Tegner >6), can perform the required tasks, can undergo MRI, and can provide informed consent.

Probably not a fit

Patients with prior lower-limb surgeries, neurological disorders, MRI contraindications, pregnancy, active cancer, or those outside the 18–30 high-activity range are unlikely to benefit or are excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults who have undergone anterior cruciate ligament reconstruction will complete a dedicated neuromotor training program and undergo functional MRI scanning. The study measures volumetric activation in cortical motor and sensorimotor regions during lower-limb tasks before and after the training intervention. Eligible participants are physically active young adults (Tegner >6) without neurological disorders or prior lower-limb surgeries and who can safely undergo MRI. The goal is to link targeted rehabilitation exercises with central nervous system changes that may support improved neuromuscular control.

Why it matters

Potential benefit: If successful, this approach could help restore healthier brain activation patterns after ACL reconstruction and reduce re-injury risk by improving neuromuscular control.

How similar studies have gone: Related neuromuscular training programs have shown biomechanical and functional benefits in ACL rehabilitation, but using fMRI volumetric cortical measures to track those changes is relatively novel and evidence is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients who have undergone anterior cruciate ligament reconstruction surgery at any healthcare facility
* Able to understand and consent, adults, who have provided informed consent to participate in the study
* Male or female
* Age between 18 and 30 years at the time of signing the informed consent
* Tegner activity level \> 6

Exclusion Criteria:

* History and/or evidence of any neurological disorder or functional impairment;
* Evidence of previous surgeries on the lower limb;
* Inability to provide informed consent;
* Inability to perform the tasks required by the procedure;
* Pregnant or breastfeeding women;
* Oncology patients;
* Contraindications to undergoing MRI examinations.

Where it's running

  • IRCCS Istituto Ortopedico Rizzoli
    Bologna, Bologna, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.